"/> Novus Biologicals™ Peptide bloquant d’anticorps ME… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps METTL7B

Réf. : BL-RE-081404Réf. fabricant : 18299285 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
196410
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77337. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 13 amino acids near the amino terminus of human MettL7B.

Points forts

Source

Synthetic

(Accession #: NP_689850) The METTL7B Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081404
Réf. fabricant18299285
Gene ID (Entrez)196410
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77337. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneEC 2.1.1, EC 2.1.1.-, methyltransferase like 7 B, methyltransferase-like protein 7 B, MGC17301
Symbole de gène(s)METTL7B
Type de produitMETTL7B
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne13 amino acids near the amino terminus of human MettL7B
Une question, une configuration particulière ?
Contactez-nous pour un devis.